Charles River Laboratories
259 hedge funds and large institutions have $3.71B invested in Charles River Laboratories in 2015 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 107 increasing their positions, 90 reducing their positions, and 29 closing their positions.
267% more call options, than puts
Call options by funds: $1.31M | Put options by funds: $357K
31% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 29
26% more capital invested
Capital invested by funds: $2.95B → $3.71B (+$763M)
19% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 90
3% more funds holding
Funds holding: 252 → 259 (+7)
0.31% more ownership
Funds ownership: 98.62% → 98.93% (+0.31%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$74.4M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$37.9M |
| 3 |
Renaissance Technologies
New York
|
+$30.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$30M |
| 5 |
Millennium Management
New York
|
+$26.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$91.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$82.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$21.2M |
| 4 |
FMA
Fiduciary Management Associates
Chicago,
Illinois
|
-$20.5M |
| 5 |
AI
Ariel Investments
Chicago,
Illinois
|
-$18.1M |
CRL Hedge Fund Activity: Q1 2015 in Review
259 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2015, worth a combined $3.71B — up 26% from $2.95B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new CRL positions and 29 closed out — a net gain of 9 holders — while 107 added to existing stakes and 90 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $74.4M. The largest seller was Fairpointe Capital, cutting an estimated $91.5M.
- 259 institutional investors held Charles River Laboratories (CRL) as of Q1 2015, up from 252 in Q4 2014.
- Funds reported $3.71B of Charles River Laboratories stock for Q1 2015, up 26% quarter-over-quarter.
- 38 funds opened new Charles River Laboratories positions in Q1 2015 and 29 closed out, a net change of +9 holders.
- The largest Charles River Laboratories buyer in Q1 2015 was Fidelity Investments, an estimated $74.4M added.
- The largest Charles River Laboratories seller in Q1 2015 was Fairpointe Capital, an estimated $91.5M sold.
Based on aggregated 13F filings for Q1 2015.